This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pumphrey, C. Y. Articles by Sanderson, R. D. Search for Related Content PubMed PubMed Citation Articles by Pumphrey, C. Y. Articles by Sanderson, R. D.

Neoglycans, Carbodiimide-modified Glycosaminoglycans

A New Class of Anticancer Agents That Inhibit Cancer Cell Proliferation and Induce Apoptosis¹

Arkansas Cancer Research Center, Departments of Pathology [C. Y. P., A. M. T., R. D. S.], Anatomy [R. D. S.], Otolaryngology [S. L.], and Biometry [R. S. P.], University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205

The soluble form of the syndecan-1 heparan sulfate proteoglycan acts as a tumor suppressor molecule that inhibits growth and induces apoptosis of some cancer cell lines in vitro. Analogs of syndecan-1 were produced by carbodiimide (EDAC) conjugation of glycosaminoglycan (GAG) chains to a protein scaffold, thereby generating synthetic proteoglycans that were evaluated for anticancer properties. Surprisingly, when analyzing activities of the controls, we discovered that EDAC modified GAG chains inhibit myeloma cell viability even in the absence of protein. Here, we describe the production and the activities of these novel molecules called neoglycans. The GAG chains heparin and chondroitin sulfate (CS) were exposed to EDAC to generate the neoglycans neoheparin and neoCS, respectively. Heparin and CS in the absence of EDAC modification have no effect or a slight growth promoting effect on cancer and normal cell lines. However, neoheparin and neoCS substantially reduce cell viability by induction of apoptosis of myeloma and breast cancer cells in vitro. NeoCS when injected directly into breast tumors growing in nude mice reduces or abolishes their growth without causing apparent toxicity to the adjacent normal tissue. The neoglycans need not be continuously present in cell cultures because a short pulse exposure is sufficient to reduce cell viability. NeoCS fractions purified by size exclusion chromatography reduce myeloma cell viability, confirming the specificity of neoglycan activity. Collectively, the results of this study demonstrate the anticancer activities of this new class of GAG chain-based molecules and provide the foundation for future development of neoglycans as novel therapeutic agents.

This article has been cited by other articles:

				J.-m. Zhao, Y.-j. Wen, Q. Li, Y.-s. Wang, H.-b. Wu, J.-r. Xu, X.-c. Chen, Y. Wu, L.-y. Fan, H.-s. Yang, et al. A promising cancer gene therapy agent based on the matrix protein of vesicular stomatitis virus FASEB J, December 1, 2008; 22(12): 4272 - 4280. [Abstract] [Full Text] [PDF]

				G. W. Yip, M. Smollich, and M. Gotte Therapeutic value of glycosaminoglycans in cancer. Mol. Cancer Ther., September 1, 2006; 5(9): 2139 - 2148. [Abstract] [Full Text] [PDF]

				T. Kelly, L. J. Suva, Y. Huang, V. MacLeod, H.-Q. Miao, R. C. Walker, and R. D. Sanderson Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases Cancer Res., July 1, 2005; 65(13): 5778 - 5784. [Abstract] [Full Text] [PDF]

				H. Sun, I. M. Berquin, and I. J. Edwards Omega-3 Polyunsaturated Fatty Acids Regulate Syndecan-1 Expression in Human Breast Cancer Cells Cancer Res., May 15, 2005; 65(10): 4442 - 4447. [Abstract] [Full Text] [PDF]

				Y. Yang, V. MacLeod, M. Bendre, Y. Huang, A. M. Theus, H.-Q. Miao, P. Kussie, S. Yaccoby, J. Epstein, L. J. Suva, et al. Heparanase promotes the spontaneous metastasis of myeloma cells to bone Blood, February 1, 2005; 105(3): 1303 - 1309. [Abstract] [Full Text] [PDF]

				E. J. Joo, G. B. ten Dam, T. H. van Kuppevelt, T. Toida, R. J. Linhardt, and Y. S. Kim Nucleolin: acharan sulfate-binding protein on the surface of cancer cells Glycobiology, January 1, 2005; 15(1): 1 - 9. [Abstract] [Full Text] [PDF]

				Y. Huang, S. Wang, and T. Kelly Seprase Promotes Rapid Tumor Growth and Increased Microvessel Density in a Mouse Model of Human Breast Cancer Cancer Res., April 15, 2004; 64(8): 2712 - 2716. [Abstract] [Full Text] [PDF]